drugset / Trial / NCT00136799

Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia

NCT00136799

Phase 3 Completed 325 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the safety and tolerability of fluvastatin 80 mg in a Chinese population. This study is not recruiting patients in the US.

Timeline

Start
2005-06
Primary completion
2006-04
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluvastatin Other / unclassified 80 mg